4D Molecular Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FDMT and other ETFs, options, and stocks.About FDMT
4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution.
CEODavid H. Kirn
CEODavid H. Kirn
Employees227
Employees227
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2013
Founded2013
Employees227
Employees227
FDMT Key Statistics
Market cap609.63M
Market cap609.63M
Price-Earnings ratio-2.56
Price-Earnings ratio-2.56
Dividend yield—
Dividend yield—
Average volume1.05M
Average volume1.05M
High today$10.98
High today$10.98
Low today$10.09
Low today$10.09
Open price$10.11
Open price$10.11
Volume407.30K
Volume407.30K
52 Week high$12.34
52 Week high$12.34
52 Week low$2.24
52 Week low$2.24
Stock Snapshot
4D Molecular Therapeutics(FDMT) stock is priced at $10.67, giving the company a market capitalization of 609.63M. It carries a P/E multiple of -2.56.
As of 2025-11-19, 4D Molecular Therapeutics(FDMT) stock has fluctuated between $10.09 and $10.98. The current price stands at $10.67, placing the stock +5.8% above today's low and -2.8% off the high.
The 4D Molecular Therapeutics(FDMT)'s current trading volume is 407.3K, compared to an average daily volume of 1.05M.
During the past year, 4D Molecular Therapeutics(FDMT) stock moved between $2.24 at its lowest and $12.34 at its peak.
During the past year, 4D Molecular Therapeutics(FDMT) stock moved between $2.24 at its lowest and $12.34 at its peak.
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
People also own
Based on the portfolios of people who own FDMT. This list is generated using Robinhood data, and it’s not a recommendation.